Reviews

MD Exam is a telemedicine company headquartered in Miami, Florida. It offers a comprehensive online weight loss program with medication delivered at home. The program also prescribes GLP-1 receptor antagonists, including semaglutide and tirzepatide, which help reduce weight quickly. It supplies compounded versions of these medications in small batches and custom doses. Additionally, the company offers oral semaglutide for those who don’t want to administer injections. The weight loss program at MD Exam also includes support from a licensed healthcare provider and nutrition guide to ensure patients make necessary lifestyle changes to sustain their weight loss. MD Exam is available in all US states and territories. As it’s a telehealth company, it has served over 56,000 clients. Only those who medically qualify for GLP-1 antagonist medication are enrolled in the program. Unlike many other similar brands, MD Exam accepts insurance.

Brightmeds is a telehealth and wellness company that delivers weight loss medication to patients’ homes, eliminating the complex process of going through insurance and receiving meds via a pharmacy. The company exclusively focuses on weight management medications, particularly GLP-1 receptor agonists, which help shed pounds by reducing appetite. It offers two types of injectable medications: semaglutide and tirzepatide. Semaglutide is the compund found in sought-after medications like Ozempic and Wegovy, whereas tirzepatide is the generic name of the medication Zepbound. Brightmeds doesn’t offer brand-name semaglutide or tirzepatide, but instead, prescribes compounded versions of them. It has also introduced oral semaglutide. Compounded medication is more personalized but has the same active ingredient as brand-name medication. It’s typically prepared in small batches with varying dosages in licensed pharmacies at the request of a licensed healthcare provider. Brightmeds aims to make these weight loss medications affordable with compounded solutions.

Shed (formerly ShedRx) is a telehealth company dedicated to making medical weight loss accessible and affordable. The platform connects patients with licensed healthcare providers to prescribe personalized treatment plans, including weight-loss medications, supplements, and integrated health coaching. While the program originally focused on GLP-1 injections, Shed has expanded its offering to include needle-free options like sublingual liquid drops and lozenges. These treatments use the same active ingredients (semaglutide or tirzepatide) to regulate blood sugar, suppress appetite, and slow digestion, but in a more convenient daily form. Shed primarily prescribes compounded medications—custom-made versions produced in licensed pharmacies that are significantly more affordable than retail drugs. However, unlike many competitors, Shed also offers name-brand medications (such as Wegovy®, Ozempic®, and Zepbound®) for patients who prefer them or have insurance coverage. All plans include unlimited access to a clinical care team and a dedicated Member Success Manager to support your health goals.

SkinnyRx, a newcomer in the weight loss injection market, is quickly building a reputation for its innovative use of semaglutide to aid weight loss. Established a few years ago, SkinnyRx offers a structured program that combines medication with personalized telehealth consultations to address the biological aspects of appetite and weight management. Established in 2021, SkinnyRx has rapidly grown into one of the most recognized digital weight loss providers, renowned for its emphasis on safety, accessibility, and convenience. The company’s approach combines personalized medical oversight with evidence-based treatment plans to help patients achieve sustainable weight loss. SkinnyRx medications are sourced from state-licensed pharmacies that specialize in compounding. No insurance is required, and patients can pay using credit cards, FSA/HSA cards, or Buy Now, Pay Later options. Major reviews highlight the platform’s transparency, fast approval process, and responsive 24/7 support.

Hims and Hers Inc. is one of the largest telehealth services in the US. Hims Weight Loss is their dedicated arm for men’s weight management. Hims started offering telehealth services accredited by the Better Business Bureau in 2018. They are known for fast service and customized packages for expedited weight loss. In 2023, the company started rolling out name-brand GLP-1 weight loss injections. Hims makes it easy to lose weight with affordable treatment plans, 100% online. Their streamlined process ensures discretion and convenience, complete with free shipping and access to 24/7 provider messaging to guide you through your weight loss journey.

Remedy Meds is a specialized telehealth platform designed to make modern weight loss treatments accessible and affordable. The company connects patients with licensed clinicians to prescribe GLP-1 therapies—specifically compounded Semaglutide and Tirzepatide—without the need for in-person doctor visits or insurance hurdles. Legitimacy and privacy are core pillars of their service. Remedy Meds is fully HIPAA-compliant, ensuring your personal health data is encrypted and protected at all times. They are also LegitScript certified, a rigorous third-party verification that confirms they operate in compliance with healthcare laws and safety standards recognized by major platforms like Google and Visa.

In a world of always-evolving weight loss trends and plans, G-Plans is a relatively new company in the market, launching in 2021. They focus on a combined approach to weight loss, offering prescription medication and injections alongside personalized nutrition plans and fitness coaching. Their main product is a weight loss program that includes semaglutide injections, Ozempic, and Wegovy. Their customized meal plans are created based on an assessment and according to metabolism. They provide access to dedicated support staff in the industry who are available every step of the way. G-Plans emphasizes a data-driven approach and excels at a high success rate.

WeightWatchers (WW) is one of the world’s most recognized names in weight loss. Founded in 1963, it has been trusted by millions for over 60 years. Best known for its Points® system, which teaches portion control and balanced eating, the brand has evolved into a hybrid model combining lifestyle coaching, digital tools, and now clinically supervised weight‑loss medications. With the acquisition of the telehealth startup Sequence in 2023, WW expanded into prescription support, offering GLP‑1 injectables like Wegovy and Zepbound alongside oral options included in the membership. This combination of behavioral science and medical treatment positions WW as a comprehensive, evidence‑based weight management leader.

ReflexMD is a young telehealth company founded in 2023. Based in Claymont, Deleware, they offer service across the US. Since then, it has grown rapidly. ReflexMD is faster and easier to use than similar companies. They offer a streamlined process that does not sacrifice customer care for expediency. The company offers GLP-1 agonist medications for weight loss purposes. Their main product is Semaglutide, an alternative to Wegovy. Because the latter is in short supply, ReflexMD offers overnight shipping for Semaglutide.